Dr. Yazmin Odia, MD, MS, FAAN

Clinical Trials

• Trial of Combination TTF(Optune), Nivolumab Plus/Minus Ipilimumab for Bevacizumab-naïve, Recurrent Glioblastoma
• Oral ONC201 in Adult Recurrent Glioblastoma and H3 K27M-mutant Glioma

Media Releases

Get to know Neuro-Oncologist Dr. Yazmin Odia, who serves patients in Miami, Florida.

Dr. Odia is the Chief of Neuro-Oncology at Miami Cancer Institute (MCI) part of Baptist Health South Florida. She also serves on the Scientific Review Committee at MCI and the Medical Executive Committee at Baptist Hospital.

She further rounds out the Institute’s highly specialized and comprehensive brain tumor program, providing the southern two-thirds of the state, Latin America, and the Caribbean access to expert neuro-oncology care. She also collaborates with clinical experts across the organization to provide treatment to patients with malignant and benign tumors of the nervous system, including primary and metastatic brain and spine cancers. She conducts local, regional, and national clinical trials that hopefully bring significant advances in neuro-oncology cancer care to patients in South Florida, the Caribbean, and beyond.

Prior to joining Miami Cancer Institute, she was an assistant professor of neurology at Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Hospital. 

A Chicago Honor Scholar, Dr. Odia received her Bachelor of Arts degree and medical degree from the University of Chicago. She received a Master of Science degree in Clinical Research at Mayo Clinic in Rochester, Minnesota. She then completed an internship in internal medicine at Johns Hopkins Bayview Medical Center, a residency in neurology at Johns Hopkins Hospital, and a clinical and research fellowship in the Neuro-Oncology Branch of the National Institutes of Health in Bethesda, Maryland.

An expert in her field, the doctor is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the professions of psychiatry and neurology. She is also board-certified in neuro-oncology by the United Council for Neurologic Subspecialties (UCNS). The UCNS is a not-for-profit corporation that formally recognizes emerging neurologic subspecialties.

A Fellow of the American Academy of Neurology (FAAN), Dr. Odia serves as Chair of the Diversity Leadership Subcommittee and member of the Leadership Development Committee, Health Care Disparities Task Force, Spanish Language Work Group, and Undergraduate Education Subcommittee. She is also a member of the American Society of Clinical Oncology and Society for Neuro-Oncology. 

Her honors include Columbia University/New York Presbyterian Hospital’s Stephen Q. Shafer Award for Humanism in Neurology and John Hopkins’ Guy M. McKhann Award for Teaching and Communication Excellence. She also received the Top Doctor Awards in New York City (2015-2016) and Miami (2018-2021) and was named a US Castle Connolly Top Doctor (2019).

Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma are among the worst. Neuro-oncologists are neurologists who specialize in diagnosing and treating brain and nervous system cancers and administering chemotherapy to patients.

On a more personal note, Dr. Odia speaks both English and Spanish.

Recommended Articles

• Anti-Tremor Medications for Parkinson's Disease

  IntroductionParkinson’s disease is a chronic and progressive disorder. In this disorder, the movements of the individual are affected. When we say progressive, it means that as time passes by, the symptoms related to the disease tend to worsen. Parkinson’s disease does not have a complete cure...

• Blocking Enzymes May Be the Key to Alzheimer's Treatment

  Scientists at the Massachusetts Institute of Technology (MIT) have been working on a potential new treatment for Alzheimer’s disease. They are honing in on the genetics involved, hoping to hijack enzymes to do the job.There are genes that turn on to help us make new memories.It’s been shown in...

• Taking Plavix and Root Canal Treatment

  Generic Name: ClopidogrelBrand Name: PlavixWhat is Plavix?Plavix is a drug that prevents the platelets in the blood from sticking together, thereby avoiding the formation of blood clots. There can be unwanted cases of blood clots, which can occur in cases of heart diseases or blood vessel...

• What Is Hyperalgesia?

  Introduction Can you imagine having a small bruise but feel like someone has hit you with a sledgehammer? If you can imagine the scenario or may have even felt it at some point in your life, then you must know what it's like to have hyperalgesia.Hyperalgesia is a medical term, which means that the...

• How Is Stroke Diagnosed?

  A stroke is often diagnosed by conducting physical examination tests and studying brain images produced during scans. Your doctor will try to find all the information regarding the symptoms of stroke. In addition, the doctor will carry out a number of tests to ascertain if you have a stroke. The...

• Protein Interactions May Help Explain Memory Loss with Parkinson's

  Up until recently, scientists only knew that as Parkinson’s disease progresses so do all of its symptoms, particularly around memory loss.  They also knew that as many as 30% of Parkinson’s sufferers develop dementia.  What they didn’t know was why or, really how they treat it in...